PPRCH-08 - Healthcare professionals’ and consumers’ awareness and understanding of the Black Triangle Scheme and its influence on adverse drug event reporting in Australia: a mixed-methods study

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPRCH-08
• By: GEBREYOHANNES, Eyob Alemayehu (Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Australia)
• Co-author(s): Dr Eyob Alemayehu Gebreyohannes (Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia / Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Australia)
  Dr Sieta T de Vries (Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands)
  Dr Christopher Thornton (UniSA Creative, University of South Australia, Adelaide, Australia)
  Mr Mohammed Gebre Dedefo (Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia)
  Associate Prof Oliver Frank (Discipline of General Practice, Adelaide Medical School, University of Adelaide, Adelaide, Australia)
  Dr Myra Thiessen (Monash Art, Design and Architecture, Monash University, Melbourne, Australia)
  Associate Prof Lisa Kalisch Ellett (UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia)
  Dr Renly Lim (Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia)
  
• Abstract:

  Introduction:
  In pharmacovigilance, it is considered important to report all adverse drug events (ADEs) to regulatory authorities. However, priority is given to several specific ADEs, including ADEs for medicines included in the Black Triangle Scheme. In Australia, the Black Triangle Scheme was introduced by the Therapeutic Goods Administration..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login